1. تاثیر عصاره هیدروالکلی زنجبیل بر میزان پروفایل لیپیدی موشهای صحرایی نر به دنبال دریافت دوکسوروبیسین.
- Author
-
مرضیه نیاکان, حبیب اله جوهری, and مهرداد شریعتی
- Subjects
- *
LIPID metabolism , *EXPERIMENTAL design , *STATISTICS , *TRIGLYCERIDES , *HDL cholesterol , *GINGER , *ANALYSIS of variance , *DOXORUBICIN , *ANIMAL experimentation , *LDL cholesterol , *RATS , *DATA analysis software , *DATA analysis , *LIPIDS - Abstract
Introduction: Doxorubicin leads to lipid profile disorders. The aim of this study was to evaluate the effect of hydroalcoholic extract of ginger (Zingiber officinale) on the lipid profile of male rats after receiving doxorubicin. Material and Methods: In this experimental study, 63 adult male rats were divided into 7 groups of 9: control group, sham group: received distilled water. Experimental group 1 received 20 mg / kg/ bw doxorubicin intraperitoneally, experimental groups 2 and 3 received 300 mg / kg/ bw and 600 mg / kg/ bw of hydroalcoholic extract of ginger orally for 2 months, respectively. Experimental groups 5 and 4 received doxorubicin and hydroalcoholic extract of ginger (20 mg / kg/ bw + 300 mg / kg/ bw) and (20 mg / kg/ bw + 600 mg / kg/ bw), respectively for 2 months. After the end of the experimental period, blood samples were collected and serum levels of lipid profiles were measured. Data were analyzed using SPSS software version 19 and the groups were compared by ANOVA and Tukey test. Results: Serum levels of triglyceride, total cholesterol, and LDL cholesterol were significantly increased in the doxorubicin group compared to the control group. Serum HDL cholesterol levels in the doxorubicin group showed a significant decrease compared to the control group. Serum levels of triglycerides, total cholesterol, LDL cholesterol and HDL cholesterol in the groups (20 mg / kg/ bw + 300 mg / kg/ bw) and (20 mg / kg/ bw + 600 mg / kg/ bw) showed a significant decrease compared to the doxorubicin group (P <0.05). Conclusion: Ginger hydroalcoholic extract probably improved its lipid profile after receiving doxorubicin due to its antioxidant properties. [ABSTRACT FROM AUTHOR]
- Published
- 2022